Manufacturing Challenges for Biosimilars: Complex Production Explained
Biosimilars are not like generics - they're complex proteins made in living cells, making their manufacturing far more difficult. Learn why glycosylation, scale-up, and regulation create huge hurdles - and how new tech is helping.